Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources Investors Careers News About Store Community Contact Support

G42 Healthcare signs distribution agreement for Oxford Nanopore Technologies’ sequencing products

Tue 19th July 2022

G42 Healthcare, the Abu Dhabi-based health-tech company, today announced the signing of a distribution agreement with Oxford Nanopore as a channel partner for their DNA/RNA sequencing products across Gulf Co-operation Council (GCC) countries, Jordan, Pakistan, Egypt, and Iraq. You can read G42 Healthcare's announcement in full here